Ventripoint Diagnostics Holds Annual Shareholder Meeting

Metro Loud
2 Min Read

Ventripoint Diagnostics Ltd. convened its Annual and Special Meeting of Shareholders, initiating the formal proceedings with a scheduled duration of approximately ten minutes before transitioning to discussions on company activities. The meeting commenced precisely at 11:00 AM.

Meeting Formalities and Procedural Matters

George Adams, Executive Chairman and Corporate Secretary, formally opened the meeting. A key procedural item involved the appointment of individuals to oversee meeting proceedings and report on share attendance. Daniel [indiscernible] from Computershare Trust Company of Canada, the company’s transfer agent and registrar, was appointed to report on the number of shareholders present in person and by proxy, and to tally votes on any matters requiring a poll.

Shareholder Communication and Notice Distribution

Adams detailed the distribution method for meeting materials. The notice calling the meeting and the accompanying management information circular were disseminated to all registered and non-registered shareholders using the notice and access provision, as permitted by applicable securities regulations. This approach involved posting electronic versions of proxy-related materials online, a strategy implemented to reduce postage and material expenses, while also offering environmental benefits through reduced paper waste.

Physical copies of the proxy form and a supplemental notice and access card were mailed to all shareholders. The company expressed gratitude to a shareholder who provided feedback, indicating an effort to improve the communication process and address potential background noise issues during virtual interactions.

Company Participants

Key company representatives present and participating in the meeting included:

  • George Adams – Executive Chairman & Corporate Secretary
  • Hugh MacNaught – CEO, President & Director
  • Dana Friesen
  • David Swetlow – Chief Financial Officer
Share This Article